BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1707692)

  • 1. Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells.
    Fazely F; Dezube BJ; Allen-Ryan J; Pardee AB; Ruprecht RM
    Blood; 1991 Apr; 77(8):1653-6. PubMed ID: 1707692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group.
    Dezube BJ; Pardee AB; Chapman B; Beckett LA; Korvick JA; Novick WJ; Chiurco J; Kasdan P; Ahlers CM; Ecto LT
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):787-94. PubMed ID: 8099612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
    Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA
    AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
    Angel JB; Saget BM; Walsh SP; Greten TF; Dinarello CA; Skolnik PR; Endres S
    AIDS; 1995 Oct; 9(10):1137-44. PubMed ID: 8519449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide inhibits the replication of human immunodeficiency virus type 1.
    Makonkawkeyoon S; Limson-Pobre RN; Moreira AL; Schauf V; Kaplan G
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5974-8. PubMed ID: 8327469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy.
    Wilt SG; Milward E; Zhou JM; Nagasato K; Patton H; Rusten R; Griffin DE; O'Connor M; Dubois-Dalcq M
    Ann Neurol; 1995 Mar; 37(3):381-94. PubMed ID: 7695238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
    Herbein G; Montaner LJ; Gordon S
    J Virol; 1996 Nov; 70(11):7388-97. PubMed ID: 8892857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline for the treatment of HIV infection and its complications.
    Dezube BJ; Lederman MM
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S139-42. PubMed ID: 8699854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.
    Simon G; Moog C; Obert G
    Chem Biol Interact; 1994 Jun; 91(2-3):111-21. PubMed ID: 7514959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action.
    Biswas DK; Dezube BJ; Ahlers CM; Pardee AB
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):778-86. PubMed ID: 8509980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
    Rabbi MF; Finnegan A; Al-Harthi L; Song S; Roebuck KA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):321-31. PubMed ID: 9833740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism.
    Peterson PK; Gekker G; Chao CC; Hu SX; Edelman C; Balfour HH; Verhoef J
    J Clin Invest; 1992 Feb; 89(2):574-80. PubMed ID: 1310698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.
    Muñoz-Fernández MA; Navarro J; Garcia A; Punzón C; Fernández-Cruz E; Fresno M
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):838-45. PubMed ID: 9438495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
    Lacoste J; D'Addario M; Roulston A; Wainberg MA; Hiscott J
    J Virol; 1990 Oct; 64(10):4726-34. PubMed ID: 2204723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression.
    Biswas DK; Ahlers CM; Dezube BJ; Pardee AB
    Mol Med; 1994 Nov; 1(1):31-43. PubMed ID: 8790599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
    Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cell-mediated enhancement of tumour necrosis factor-alpha (TNF-alpha) production and HIV-1 LTR-driven gene expression in human monocytic cells is pertussis toxin-sensitive.
    Copeland KF; McKay PJ; Newton J; Rosenthal KL
    Clin Exp Immunol; 1999 Jun; 116(3):479-85. PubMed ID: 10361238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-2576, an inhibitor of phospholipid signaling, suppresses constitutive and induced expression of human immunodeficiency virus.
    Leung DW; Peterson PK; Weeks R; Gekker G; Chao CC; Kaplan AH; Balantac N; Tompkins C; Underiner GE; Bursten S
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4813-7. PubMed ID: 7761405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.